With its fourth transnational call (non-cofunded by the EC), ERA PerMed fosters research and innovation activities that build close linkages between clinical research, computer science/medical informatics and research on ethical, legal and social aspects (ELSA) in the field of PM.
This implies a wide range of multidisciplinary activities brought together by different stakeholders from academia, clinical/public health research and private partners such as small and medium-sized enterprises (SMEs), policy makers, regulatory/health technology assessment (HTA) agencies and patient organisations.
The overarching goal is to improve disease prevention and disease management, based on broader and more efficiently characterised and defined patient stratification, diagnostics and tailored treatment/prevention protocols for both patients and individuals at risk of disease. Early involvement of regulatory authorities and close interaction with the different key players along the value chain should be included right from the project development phase to bridge the gap between first discoveries or inventions until market access.
The call is planned to be launched on December 14th, 2020 with a submission deadline for pre-proposals on March 4th, 2021.
It is expected that consortia invited for the full-proposal stage, will need to submit their proposal on June 16th, 2021. The available budget for this call is 16 Mil€ (approx.).
For more information: http://www.erapermed.eu/pre-announcement-jtc-2021/